Lingling Zhang Selected Research

Lingling Zhang Research Topics

Disease

58	Neoplasms (Cancer) 02/2024 - 01/2014
22	Inflammation (Inflammations) 03/2024 - 05/2016
17	Infections 12/2023 - 06/2006
14	Experimental Arthritis 10/2023 - 05/2007
13	Arthritis (Polyarthritis) 01/2024 - 05/2007
10	Rheumatoid Arthritis 10/2023 - 07/2015
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 04/2017
8	Fibrosis (Cirrhosis) 01/2024 - 06/2015
8	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 12/2018
8	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2014
8	Carcinogenesis 01/2022 - 10/2014
7	Colonic Neoplasms (Colon Cancer) 12/2023 - 06/2015
6	Pain (Aches) 05/2024 - 07/2011
6	Hypoxia (Hypoxemia) 12/2023 - 01/2017
6	Stroke (Strokes) 10/2023 - 09/2010
6	Body Weight (Weight, Body) 01/2021 - 07/2011
5	Sepsis (Septicemia) 04/2023 - 11/2016
5	Breast Neoplasms (Breast Cancer) 01/2023 - 05/2013
5	Brain Ischemia (Cerebral Ischemia) 01/2023 - 01/2018
5	Bacterial Infections (Bacterial Infection) 01/2021 - 09/2014
4	Glioma (Gliomas) 05/2024 - 01/2022
4	Wounds and Injuries (Trauma) 12/2023 - 01/2016
4	Necrosis 12/2023 - 01/2018
4	Autoimmune Diseases (Autoimmune Disease) 10/2023 - 01/2018
4	Insulin Resistance 01/2023 - 01/2017
4	Ischemic Stroke 01/2023 - 11/2007
4	Immune System Diseases (Immune Disorders) 01/2023 - 01/2020
4	Adenocarcinoma of Lung 12/2022 - 08/2018
4	Melanoma (Melanoma, Malignant) 03/2022 - 01/2018
4	Cognitive Dysfunction 01/2022 - 01/2017
4	Lung Neoplasms (Lung Cancer) 03/2021 - 11/2014
4	Carcinoma (Carcinomatosis) 06/2018 - 08/2016
3	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 12/2015
3	Myocardial Infarction 03/2024 - 08/2015
3	ST Elevation Myocardial Infarction 03/2024 - 01/2023
3	Hyperplasia 12/2023 - 05/2013
3	Heart Diseases (Heart Disease) 12/2023 - 08/2015
3	Spinal Cord Injuries (Spinal Cord Injury) 02/2023 - 03/2015
3	COVID-19 01/2023 - 01/2022
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2017
3	Ischemia 01/2023 - 01/2019
3	Heart Failure 06/2022 - 01/2017
3	Vascular Remodeling 01/2021 - 12/2016
3	Substance-Related Disorders (Drug Abuse) 12/2020 - 02/2012
3	Pathologic Processes 10/2020 - 05/2016
3	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 01/2020
3	Circulating Neoplastic Cells 01/2020 - 09/2018

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 11/2023 - 06/2006
17	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2016
14	Therapeutic UsesIBA 01/2024 - 03/2011
13	CytokinesIBA 01/2023 - 05/2007
12	MicroRNAs (MicroRNA)IBA 05/2023 - 10/2014
8	Messenger RNA (mRNA)IBA 05/2023 - 10/2017
7	AntibodiesIBA 11/2023 - 02/2016
6	RNA (Ribonucleic Acid)IBA 01/2024 - 11/2015
6	EnzymesIBA 01/2024 - 01/2017
5	HydrogelsIBA 03/2024 - 03/2015
5	Phosphotransferases (Kinase)IBA 12/2022 - 01/2017
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 05/2013
4	CollagenIBA 01/2024 - 08/2015
4	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 02/2012
4	Neuroprotective AgentsIBA 10/2023 - 10/2013
4	Immunoglobulin D (IgD)IBA 06/2023 - 01/2016
4	LigandsIBA 03/2023 - 05/2011
4	LipopolysaccharidesIBA 03/2022 - 11/2016
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 03/2018
4	Monoclonal AntibodiesIBA 01/2020 - 09/2014
3	GoldIBA 05/2024 - 06/2014
3	Opioid Analgesics (Opioids)IBA 05/2024 - 10/2019
3	Tumor Biomarkers (Tumor Markers)IBA 02/2024 - 03/2021
3	InflammasomesIBA 12/2023 - 11/2016
3	Transcription Factors (Transcription Factor)IBA 12/2023 - 01/2019
3	Immunoglobulin G (IgG)IBA 11/2023 - 03/2011
3	Formaldehyde (Formol)FDA Link 10/2023 - 07/2011
3	Hematoxylin (Haematoxylon)IBA 09/2023 - 10/2020
3	Blood Glucose (Blood Sugar)IBA 09/2023 - 01/2019
3	Eosine Yellowish-(YS) (Eosin)IBA 09/2023 - 10/2020
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2023 - 05/2017
3	Long Noncoding RNAIBA 05/2023 - 05/2021
3	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2017
3	InterferonsIBA 01/2023 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2021
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 02/2015
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2017
3	Competitive Endogenous RNAIBA 01/2022 - 01/2022
3	LipidsIBA 01/2022 - 01/2018
3	peoniflorinIBA 01/2022 - 05/2007
3	Caspase 3 (Caspase-3)IBA 01/2022 - 01/2017
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 08/2018
3	Peptides (Polypeptides)IBA 03/2021 - 01/2018
3	G-Protein-Coupled Receptor Kinase 2IBA 12/2019 - 01/2017
3	Methotrexate (Mexate)FDA LinkGeneric 08/2019 - 05/2013

Therapy/Procedure

40	Therapeutics 05/2024 - 07/2010
9	Immunotherapy 01/2024 - 07/2013
8	Drug Therapy (Chemotherapy) 02/2024 - 06/2015
4	Transplantation 02/2023 - 01/2016
4	Injections 03/2022 - 01/2018
3	Percutaneous Coronary Intervention 03/2024 - 01/2023
3	Radiotherapy 01/2022 - 01/2016
3	Hematopoietic Stem Cell Transplantation 03/2021 - 02/2016